The reason is that the traditional prostate cancer screening test – a blood test to measure prostate specific antigen, or PSA – does not give doctors a complete picture.
Now, the University of Michigan Health System has begun offering a new urine test called Mi-Prostate Score to improve on PSA screening for prostate cancer. The test incorpora [...]
The FDA has approved the osteoporosis drug Prolia as a treatment for some breast and prostate cancer patients whose bones have been weakened by certain hormone therapies for cancer.
The drug’s manufacturer, Amgen Inc., says studies showed that Prolia improved bone mass and reduced the occurrence of new spine fractures in men with prosta [...]
A new urine test can help aid early detection of and treatment decisions about prostate cancer, a study from the University of Michigan Comprehensive Cancer Center and the Michigan Center for Translational Pathology finds.
The test supplements an elevated prostate specific antigen, or PSA, screening result, and could help some men delay or av [...]